Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk

Clinical and Developmental Immunology
doi 10.1155/2012/760965
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer

Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer ResearchAllergyImmunologyPharmacology
2015English

Reprogramming the Microenvironment With Tumor-Selective Angiotensin Blockers Enhances Cancer Immunotherapy

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Improving Cancer Immunotherapy by Targeting Tumor-Induced Immune Suppression

Cancer and Metastasis Reviews
Cancer ResearchOncology
2011English

Cancer Immunotherapy: Designing Bioinspired 2D MoSe 2 Nanosheet for Efficient Photothermal‐Triggered Cancer Immunotherapy With Reprogramming Tumor‐Associated Macrophages (Adv. Funct. Mater. 30/2019)

Advanced Functional Materials
Materials ScienceCondensed Matter PhysicsElectrochemistryNanoscienceOpticalBiomaterialsMagnetic MaterialsNanotechnologyChemistryElectronic
2019English

Human Tumor Antigens and Cancer Immunotherapy

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

The Blockade of Immune Checkpoints in Cancer Immunotherapy

Nature Reviews Cancer
Cancer ResearchOncology
2012English

Endometrial Tumor Immune Response: Predictive Biomarker of Response to Immunotherapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Enhanced Tumor Immune Surveillance Through Neutrophil Reprogramming Due to Tollip Deficiency

JCI insight
Medicine
2019English

Cancer Immunotherapy - Converting Immune Failure to Clinical Response

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy